Germany
Japan
United Kingdom
China
TissueScan, Prostate Cancer cDNA Array III
48 samples covering 9-normal, 18-Stage II, 19-III, 2-IV. Available in 2, 5, 10 identical plates.
Product Datasheet for 'HPRT103'
USD 850.00
Product images
Specifications
| Product Data | |
| Array Category | Cancer Specific |
| Clinical Info | |
| Diagnosis | Prostate Cancer |
| Tissue | Prostate |
| Array Name | Prostate Cancer cDNA Array III |
Citations (11)
| The use of this Tissues has been cited in the following citations: |
|---|
|
Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5
,Lin, CY;Jan, YJ;Kuo, LK;Wang, BJ;Huo, C;Jiang, SS;Chen, SC;Kuo, YY;Chang, CR;Chuu, CP;,
Cancer Sci. 2018
,PubMed ID 30142696
[Prostate Cancer HPRT101]
|
|
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling
,Pai, VC;Hsu, CC;Chan, TS;Liao, WY;Chuu, CP;Chen, WY;Li, CR;Lin, CY;Hwang, SP;Chen, LT;Tsai, KK;,
Oncogene 2018
,PubMed ID 30266990
[Prostate Cancer]
|
|
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
,Thiele, S;Zimmer, A;Göbel, A;Rachner, TD;Rother, S;Fuessel, S;Froehner, M;Wirth, MP;Muders, MH;Baretton, GB;Jakob, F;Rauner, M;Hofbauer, LC;,
Oncotarget 2018
,PubMed ID 29930766
[Prostate Cancer]
|
|
TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis
,Singh, R;Karri, D;Shen, H;Shao, J;Dasgupta, S;Huang, S;Edwards, DP;Ittmann, MM;O'Malley, BW;Yi, P;,
J. Clin. Invest. 2018
,PubMed ID 29715200
[Prostate Cancer]
|
|
Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis
,Ko, CJ;Lan, SW;Lu, YC;Cheng, TS;Lai, PF;Tsai, CH;Hsu, TW;Lin, HY;Shyu, HY;Wu, SR;Lin, HH;Hsiao, PW;Chen, CH;Huang, HP;Lee, MS;,
Oncogene 2017
,PubMed ID 28368394
[Prostate Cancer]
|
|
ZFP91: A Noncanonical NF-?B Signaling Pathway Regulator with Oncogenic Properties Is Overexpressed in Prostate Cancer
,Paschke, L;Jopek, K;Szyszka, M;Tyczewska, M;Ziolkowska, A;Rucinski, M;Malendowicz, LK;,
Biomed Res Int 2016
,PubMed ID 27975057
[Prostate Cancer]
|
|
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
,Lin, VC;Lu, TL;Yin, HL;Yang, SF;Lee, YC;Liu, CC;Huang, CY;Yu, CC;Chang, TY;Huang, SP;Bao, BY;,
Int J Mol Sci 2016
,PubMed ID 27916838
[Prostate Cancer]
|
|
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer
,Qin, F;Song, Z;Chang, M;Song, Y;Frierson, H;Li, H;,
Cancer Lett. Jun 2016
,PubMed ID 27322736
|
|
Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis
,Hu, X;Garcia, C;Fazli, L;Gleave, M;Vitek, MP;Jansen, M;Christensen, D;Mulholland, DJ;,
Sci Rep Nov 2015
,PubMed ID 26563471
[HPRT103]
|
|
WNT5A has Anti-Prostate Cancer Effects In Vitro and Reduces Tumor Growth in the Skeleton In Vivo
,Thiele, S;Göbel, A;Rachner, TD;Fuessel, S;Froehner, M;Muders, MH;Baretton, GB;Bernhardt, R;Jakob, F;Glüer, CC;Bornhäuser, M;Rauner, M;Hofbauer, LC;,
J. Bone Miner. Res. Sep 2014
,PubMed ID 25224731
[HP100041]
|
|
FGF-2 Disrupts Mitotic Stability in Prostate Cancer through the Intracellular Trafficking Protein CEP57
,Rolando Cuevas, Nina Korzeniewski, Yanis Tolstov, Markus Hohenfellner, and Stefan Duensing,
Cancer Res., Feb 2013; 73: 1400 - 1410.
[Prostate Cancer cDNA Array III]
|
Documents
| Product Manuals |
| FAQs |
| SDS |
USD 120.00
USD 120.00
USD 331.00
USD 179.00
